Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale
{{output}}
Background: The TRACE III trial showed that for patients with large arterial occlusion presenting 4.5-24 hours of symptom occurrence and a salvageable penumbra on perfusion imaging, intravenous tenecteplase (TNK) thrombolysis is ... ...
